loratadine has been researched along with Febrile Neutropenia in 1 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Febrile Neutropenia: Fever accompanied by a significant reduction in the number of NEUTROPHILS.
Excerpt | Relevance | Reference |
---|---|---|
"Type of cancer, treatment, age, and BMI were not significant predictors of bone pain." | 1.46 | Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade. ( Abrams, M; Gavioli, E, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gavioli, E | 1 |
Abrams, M | 1 |
1 other study available for loratadine and Febrile Neutropenia
Article | Year |
---|---|
Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade.
Topics: Aged; Antineoplastic Agents; Bone Diseases; Cohort Studies; Famotidine; Febrile Neutropenia; Female; | 2017 |